1. Home
  2. GLP vs SRPT Comparison

GLP vs SRPT Comparison

Compare GLP & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLP
  • SRPT
  • Stock Information
  • Founded
  • GLP 2005
  • SRPT 1980
  • Country
  • GLP United States
  • SRPT United States
  • Employees
  • GLP N/A
  • SRPT N/A
  • Industry
  • GLP Oil Refining/Marketing
  • SRPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GLP Energy
  • SRPT Health Care
  • Exchange
  • GLP Nasdaq
  • SRPT Nasdaq
  • Market Cap
  • GLP 1.7B
  • SRPT 1.9B
  • IPO Year
  • GLP 2005
  • SRPT 1997
  • Fundamental
  • Price
  • GLP $45.21
  • SRPT $24.01
  • Analyst Decision
  • GLP Hold
  • SRPT Hold
  • Analyst Count
  • GLP 1
  • SRPT 30
  • Target Price
  • GLP $56.00
  • SRPT $36.59
  • AVG Volume (30 Days)
  • GLP 42.4K
  • SRPT 4.6M
  • Earning Date
  • GLP 11-07-2025
  • SRPT 11-03-2025
  • Dividend Yield
  • GLP 6.64%
  • SRPT N/A
  • EPS Growth
  • GLP N/A
  • SRPT N/A
  • EPS
  • GLP 2.60
  • SRPT N/A
  • Revenue
  • GLP $17,827,598,000.00
  • SRPT $2,481,531,000.00
  • Revenue This Year
  • GLP $37.98
  • SRPT $9.68
  • Revenue Next Year
  • GLP $28.27
  • SRPT N/A
  • P/E Ratio
  • GLP $17.39
  • SRPT N/A
  • Revenue Growth
  • GLP 3.74
  • SRPT 64.89
  • 52 Week Low
  • GLP $43.20
  • SRPT $10.42
  • 52 Week High
  • GLP $60.00
  • SRPT $138.81
  • Technical
  • Relative Strength Index (RSI)
  • GLP 40.42
  • SRPT 60.36
  • Support Level
  • GLP $44.18
  • SRPT $22.80
  • Resistance Level
  • GLP $46.37
  • SRPT $24.38
  • Average True Range (ATR)
  • GLP 1.20
  • SRPT 1.09
  • MACD
  • GLP 0.22
  • SRPT -0.02
  • Stochastic Oscillator
  • GLP 62.09
  • SRPT 86.78

About GLP Global Partners LP Common Units representing Limited Partner Interests

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Share on Social Networks: